4D Molecular Therapeutics, Inc. (FDMT)

CIK 1650648 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for 4D Molecular Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 202640001193125-26-382245
Aug 21, 202640001193125-26-361096
Aug 19, 20261440001958244-26-000539
Aug 17, 20261440001950047-26-008269
Aug 17, 202640001193125-26-354313
Aug 13, 20261440001950047-26-008088
Aug 13, 202610-Q0001193125-26-349173
Aug 13, 20268-K0001193125-26-349160
Aug 5, 202640001193125-26-335115
Aug 4, 20261440001958244-26-000477
Aug 4, 202640001193125-26-333014
Aug 3, 20261440001958244-26-000473
Jul 20, 20268-K0001193125-26-308409
Jul 14, 202640001834021-26-000004
Jul 10, 20261440001958244-26-000446
Jul 9, 20261440001958244-26-000444
Jul 2, 202640001920738-26-000004
Jun 30, 20261440001950047-26-006669
Jun 29, 20268-K0001193125-26-286880
Jun 25, 202640001920738-26-000002
Jun 23, 202640001834021-26-000002
Jun 23, 20261440001950047-26-006432
Jun 22, 20268-K0001193125-26-277563
Jun 22, 20261440001958244-26-000396
Jun 18, 202640001193125-26-276144